1. Home
  2. CHEK vs AIMD Comparison

CHEK vs AIMD Comparison

Compare CHEK & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • AIMD
  • Stock Information
  • Founded
  • CHEK 2004
  • AIMD 1984
  • Country
  • CHEK Israel
  • AIMD United States
  • Employees
  • CHEK N/A
  • AIMD N/A
  • Industry
  • CHEK Medical Electronics
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHEK Health Care
  • AIMD Health Care
  • Exchange
  • CHEK Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • CHEK 9.0M
  • AIMD 8.5M
  • IPO Year
  • CHEK 2015
  • AIMD N/A
  • Fundamental
  • Price
  • CHEK $0.77
  • AIMD $0.62
  • Analyst Decision
  • CHEK
  • AIMD
  • Analyst Count
  • CHEK 0
  • AIMD 0
  • Target Price
  • CHEK N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • CHEK 72.4K
  • AIMD 227.7K
  • Earning Date
  • CHEK 03-04-2025
  • AIMD 03-07-2025
  • Dividend Yield
  • CHEK N/A
  • AIMD N/A
  • EPS Growth
  • CHEK N/A
  • AIMD N/A
  • EPS
  • CHEK N/A
  • AIMD N/A
  • Revenue
  • CHEK N/A
  • AIMD $40,633.00
  • Revenue This Year
  • CHEK N/A
  • AIMD N/A
  • Revenue Next Year
  • CHEK N/A
  • AIMD N/A
  • P/E Ratio
  • CHEK N/A
  • AIMD N/A
  • Revenue Growth
  • CHEK N/A
  • AIMD N/A
  • 52 Week Low
  • CHEK $0.56
  • AIMD $0.40
  • 52 Week High
  • CHEK $3.45
  • AIMD $3.10
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 38.09
  • AIMD 47.20
  • Support Level
  • CHEK $0.81
  • AIMD $0.56
  • Resistance Level
  • CHEK $0.92
  • AIMD $0.77
  • Average True Range (ATR)
  • CHEK 0.08
  • AIMD 0.06
  • MACD
  • CHEK -0.01
  • AIMD -0.01
  • Stochastic Oscillator
  • CHEK 22.17
  • AIMD 28.67

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: